“…A recent review, based on the only 4 available clinical studies of imaging testing in patients with TTS [14], summarized the information on: 1) myocardial perfusion, employing single photon emission computed tomography (SPECT) or positron emission tomography (PET) scanning, and Thallium-201, nitrogen 13-ammonia, and 99 mTc-tetrofosmin as radiotracers, which showed a range of findings, consisting of normal myocardial perfusion at rest, a slight reduction in tracer uptake after adenosine in the apex and apical segments of the left ventricle (LV) that normalized at rest, significant reduction of myocardial blood flow and coronary flow reserve in the apical segments in comparison to the mid-ventricular and basal LV segments, and a decreased radiotracer uptake in only a small area of the apex, with complete restoration of normality at follow-up imaging, 2) myocardial glucose metabolism, employing myocardial PET using fluorine 18 fluorodeoxyglucose (FDG), which showed severe and diffuse reduced 18F-FDG uptake in the LV, with the extension of the metabolic defect being much larger and more severe than the perfusion defect with 201 Tl SPECT imaging in the acute phase of TTS, with recovery at follow-up after the normalization of the LV function; 3) assessment of myocardial innervation, employing myocardial 123 I-metaiodobenzylguanidine (mIBG) SPECT, which disclosed a severe reduction/absence of mIBG uptake (denervation) in the normally perfused but dysfunctional segments of apical or mid-ventricular LV regions, with overlapping defects of myocardial glucose metabolism and myocardial denervation, and repeated 123 I-mIBG SPECT six months after acute symptoms, demonstrating an improvement of tracer uptake or complete normalization of innervation in the LV apical segments. The authors of the review [14] speculated that the heretofore unexplained severe reduction of FDG uptake in the dysfunctional LV myocardial segments, associated with an overlapping pattern of severe denervation, both of which were ameliorated and even normalized in the follow-up after the improvement of myocardial function, might be related to a specific metabolic impairment of the glucose utilization in the presence of normal perfusion ("inverse flow metabolism mismatch"), constitute a transient metabolic disorder on the cellular level (functional), rather than a structural contractile disease of the myocardium, that might be related to a coronary microcirculation impairment, followed by prolonged myocardial stunning.…”